Mar 24,2023

Medtronic prices $2 billion of senior notes

Medtronic announced that its Medtronic Global Holdings S.C.A subsidiary priced an offering of senior notes worth $2 billion. The financial move comes at the same time that the world’s largest medical device company engages in significant expense reductions. The idea is to boost the company’s resilience against the present macroeconomic headwinds. The wholly-owned subsidiary — Medtronic Luxco — priced the offering of two different groups of senior notes. The first, with a principal amount of $1 million, includes 4.25% senior notes due in 2028. Medtronic Luxco’s second group of notes features $1 million of 4.5% senior notes due 2023.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Feb 13,2020

Carevive Systems Raises New Financing Round With Philips and Debiopharm to Accelerate Advances in Cancer Care Delivery

Carevive Systems, a leading oncology-focused health technology company, announced today that it has received Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund, and existing investors Cerner Capital, HLM Venture Partners, LRV Health, and Co-Founder/CEO Madelyn Trupkin Herzfeld. This new funding round will strengthen Carevive’s position as the market leader in understanding and improving the cancer patient experience. 

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Feb 04,2018

OWise receives top prize in Scotland’s Cancer Innovation Challenge

OWise received a £100,000 award to progress to the second phase of Scotland’s prestigious Cancer Innovation Challenge. It was one of the projects selected to progress to phase two of the Cancer Innovation Challenge, which aimed to inspire novel data and tech innovations to help Scotland become a world leader in cancer care.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Mar 10,2020

OWise wins top NESTA Healthier Lives Data Fund Prize

Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland. This funding was in addition to the £30,000 originally awarded to organisations involved in the Healthier Lives Data Fund. This fund is a partnership between Nesta and the Scottish Government which, over the last year, has supported six projects in Scotland that demonstrated what can be achieved when health or care data is used to give control back to the individual.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Apr 25,2022

Biofourmis Receives Significant Growth Investment from General Atlantic to Surpass Unicorn Status

Biofourmis, a global leader in virtual care and digital medicine, today announced it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. CVS Health (NYSE: CVS) and existing investors also participated in the round, which will help fuel the company’s next phase of growth. Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Aug 09,2016

Analytics startup Biofourmis gets US$1M funding led by SpesNet

Biofourmis, Singapore-based personalised physiological data analytics firm, today announced that the company has secured US$1 million in angel funding, led by SpesNet and Eden Strategy. Biofourmis has been actively working with the healthcare sector to offer predictive, precise and meaningful insights into one’s health.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 20,2019

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Medicine Platform

Biofourmis, a fast-growing leader in digital medicine, today announced that it has successfully closed $35 million in Series B financing. The new injection of funding and move to the U.S. will enable Biofourmis to advance its proprietary artificial intelligence (AI)-powered digital medicine platform and pipeline that treats and manages a range of complex chronic conditions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 11,2017

Mayo Clinic deal and $5m funding for health data platform Biofourmis

Singapore-based health analytics platform Biofourmis announced the close of its series A funding round today, while also unveiling a partnership with US medical research institute, the Mayo Clinic. The startup raised US$5 million from NSI Ventures – part of Singaporean private equity firm Northstar Group – and Aviva Ventures, the VC arm of UK insurance company Aviva. Biofourmis will use the series A capital to scale its operations and fund the commercial launch of Biovitals.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 07,2019

SidekickHealth gets an injection from Novator

Novator, Björgólf Thor Björgólfsson's investment company, and related investors have completed a one hundred million ISK injection into the Icelandic health technology company SidekickHealth, but the investor group has contributed hundreds of millions to the company since its inception. SidekickHealth has one foot in the door of the global pharmaceutical industry after successfully partnering with two of the world's five largest pharmaceutical companies. A second and larger capital increase is planned for the end of the year.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 22,2017

Acceptance of capital from Japan Post Group

Tokyo-based company, Wellby, which supports the health management of people facing illnesses, has announced that it will carry out a third-party allotment of shares to Japan Post Capital Co., Ltd. and proceed with a partnership with Japan Post Group. By utilizing Japan Post Group's brand and network, Wellby aims to further promote the use of PHR and contribute to medical institutions, regions, and municipalities.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING